NOW vs. REGN

Last updated Jun 13, 2026

NOW (ServiceNow, Inc) and REGN (Regeneron Pharmaceuticals, Inc.) are both stocks. NOW operates in Software - Application (Technology), while REGN operates in Biotechnology (Healthcare). Over the past 10 years, NOW returned 21.48%/yr vs 5.35%/yr for REGN. At a 0.27 correlation, their price movements are largely independent.

Performance

NOW vs. REGN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ServiceNow, Inc (NOW) and Regeneron Pharmaceuticals, Inc. (REGN). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NOW achieves a -33.32% return, which is significantly lower than REGN's -20.48% return. Over the past 10 years, NOW has outperformed REGN with an annualized return of 21.48%, while REGN has yielded a comparatively lower 5.35% annualized return.

NOW

• 1D: -0.90%
• 1M: 12.87%
• YTD: -33.32%
• 6M: -40.96%
• 1Y: -48.34%
• 3Y*: -2.72%
• 5Y*: 0.51%
• 10Y*: 21.48%

REGN

• 1D: 0.11%
• 1M: -14.00%
• YTD: -20.48%
• 6M: -17.20%
• 1Y: 16.30%
• 3Y*: -7.00%
• 5Y*: 3.27%
• 10Y*: 5.35%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NOW vs. REGN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NOW ServiceNow, Inc	-33.32%	-27.75%	50.05%	81.96%	-40.18%	17.93%	94.97%	58.56%	36.55%	75.40%
REGN Regeneron Pharmaceuticals, Inc.	-20.48%	8.96%	-18.90%	21.73%	14.25%	30.72%	28.66%	0.53%	-0.65%	2.42%

Correlation

The correlation between NOW and REGN is -0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.10
Correlation (3Y) Calculated over the trailing 3-year period	0.05
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (10Y) Calculated over the trailing 10-year period	0.24
Correlation (All Time) Calculated using the full available price history since Jun 29, 2012	0.27

The correlation between NOW and REGN shifts across timeframes, from -0.10 (1 year) to 0.27 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap NOW : $106.24B REGN : $65.93B
EPS NOW : $1.68 REGN : $41.05
PE Ratio NOW : 60.81 REGN : 14.91
PS Ratio NOW : 7.65 REGN : 4.42
PB Ratio NOW : 7.83 REGN : 2.10
Total Revenue (TTM) NOW : $13.96B REGN : $14.92B
Gross Profit (TTM) NOW : $10.69B REGN : $12.61B
EBITDA (TTM) NOW : $2.80B REGN : $5.74B

Return for Risk

NOW vs. REGN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NOW

NOW Risk / Return Rank: 8
NOW Sharpe Ratio Rank: 5
NOW Sortino Ratio Rank: 7
NOW Omega Ratio Rank: 7
NOW Calmar Ratio Rank: 11
NOW Martin Ratio Rank: 8

REGN

REGN Risk / Return Rank: 59
REGN Sharpe Ratio Rank: 62
REGN Sortino Ratio Rank: 56
REGN Omega Ratio Rank: 55
REGN Calmar Ratio Rank: 59
REGN Martin Ratio Rank: 63

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NOW vs. REGN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ServiceNow, Inc (NOW) and Regeneron Pharmaceuticals, Inc. (REGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	NOW	REGN	Difference
Sharpe ratio: Return per unit of total volatility	-0.99	0.55	-1.54
Sortino ratio: Return per unit of downside risk	-1.44	1.00	-2.44
Omega ratio: Gain probability vs. loss probability	0.82	1.12	-0.31
Calmar ratio: Return relative to maximum drawdown	-0.82	0.70	-1.52
Martin ratio: Return relative to average drawdown	-1.45	2.16	-3.61

NOW vs. REGN - Sharpe Ratio Comparison

The current NOW Sharpe Ratio is -0.99, which is lower than the REGN Sharpe Ratio of 0.55. The chart below compares the historical Sharpe Ratios of NOW and REGN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

NOW vs. REGN - Drawdown Comparison

The maximum NOW drawdown since its inception was -64.54%, smaller than the maximum REGN drawdown of -91.81%. Use the drawdown chart below to compare losses from any high point for NOW and REGN.

Drawdown Indicators

	NOW	REGN	Difference
Max Drawdown Largest peak-to-trough decline	-64.54%	-91.81%	+27.27%
Max Drawdown (1Y) Largest decline over 1 year	-60.28%	-25.85%	-34.43%
Max Drawdown (3Y) Largest decline over 3 years	-64.54%	-59.69%	-4.85%
Max Drawdown (5Y) Largest decline over 5 years	-64.54%	-59.69%	-4.85%
Max Drawdown (10Y) Largest decline over 10 years	-64.54%	-59.69%	-4.85%
Current Drawdown Current decline from peak	-56.36%	-48.64%	-7.72%
Average Drawdown Average peak-to-trough decline	-13.78%	-42.45%	+28.67%
Ulcer Index Depth and duration of drawdowns from previous peaks	34.02%	8.33%	+25.69%

Volatility

NOW vs. REGN - Volatility Comparison

ServiceNow, Inc (NOW) has a higher volatility of 25.56% compared to Regeneron Pharmaceuticals, Inc. (REGN) at 12.77%. This indicates that NOW's price experiences larger fluctuations and is considered to be riskier than REGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NOW	REGN	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.56%	12.77%	+12.79%
Volatility (6M) Calculated over the trailing 6-month period	47.01%	22.14%	+24.87%
Volatility (1Y) Calculated over the trailing 1-year period	50.12%	32.77%	+17.35%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.44%	30.79%	+12.65%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	40.86%	32.17%	+8.69%

Dividends

NOW vs. REGN - Dividend Comparison

NOW has not paid dividends to shareholders, while REGN's dividend yield for the trailing twelve months is around 0.59%.

Position	TTM	2025
NOW ServiceNow, Inc	0.00%	0.00%
REGN Regeneron Pharmaceuticals, Inc.	0.59%	0.46%

Financials

NOW vs. REGN - Profitability Comparison

The chart below illustrates the profitability comparison between ServiceNow, Inc and Regeneron Pharmaceuticals, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

NOW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ServiceNow, Inc reported a gross profit of 2.83B and revenue of 3.77B. Therefore, the gross margin over that period was 75.1%.

REGN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported a gross profit of 2.94B and revenue of 3.61B. Therefore, the gross margin over that period was 81.4%.

NOW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ServiceNow, Inc reported an operating income of 503.00M and revenue of 3.77B, resulting in an operating margin of 13.3%.

REGN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported an operating income of 642.90M and revenue of 3.61B, resulting in an operating margin of 17.8%.

NOW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ServiceNow, Inc reported a net income of 469.00M and revenue of 3.77B, resulting in a net margin of 12.4%.

REGN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported a net income of 727.20M and revenue of 3.61B, resulting in a net margin of 20.2%.

Frequently Asked Questions

Can I hold both NOW and REGN in my portfolio?

NOW and REGN have a correlation of -0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NOW or REGN?

NOW has higher volatility (25.56%) compared to REGN (12.77%). In terms of maximum drawdown, NOW dropped -64.54% vs REGN's -91.81%.

Which has better risk-adjusted returns?

REGN currently has the higher Sharpe Ratio (0.55 vs -0.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.